Castillo, Angelie T.
HRN: 05-00-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
MUPIROCIN 2%, 15G (TUBE)
01/31/2024
02/07/2024
TOPICAL
Apply To Affected Atea
BID
SP CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes